Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-21

Clinical Trial Update: Santyl vs. Sharp Debridement of Diabetic Foot Wounds [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Santyl collagenase ointment with sharp debridement for diabetic foot ulcers has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Santyl (collagenase)

Snippet

Sponsor: Healthpoint | Conditions: Diabetic Foot Ulcers, Foot Wounds | Phase 4 | Status: COMPLETED | Results posted: 2012-11-21